News
$TNYA - Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated
Sep 14, 2026 · ThinkSabio Blog
$TNYA - Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
14-SEP-2026 08:31 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
